Sundaresh Brahmasandra

Member, Investment Advisory Council @Clarevia Ventures

Ann Arbor, MI, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2019 — Present

Member, Investment Advisory Council @Clarevia Ventures

View department →

Madison, WI, US

Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, VI targets, uncovers, and invests in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, VI is fueling the future of what’s driving healthcare. Today, VI has over $200 million in assets under management.

EDUCATION

1990 — 1994

Indian Institute of Technology, Madras

Bachelor of Technology - BTech, Chemical Engineering

1996 — 2001

University of Michigan College of Engineering

Ph.D, Chemical Engineering

1994 — 1996

Drexel University

Chemical Engineering

SKILLS

R&DLeadershipProduct MarketingMolecularU.s. Food and Drug Administration (Fda)Medical DevicesQpcrNucleic Acid ExtractionRtpcrAssay DevelopmentMolecular DiagnosticsScientific ResearchCommercializationLifesciencesBusiness StrategyManagementStrategyStrategic PlanningBusiness DevelopmentReal-Time Polymerase Chain Reaction (Qpcr)Molecular DiagosticsProduct LaunchLife SciencesCross-Functional Team LeadershipVenture CapitalBiotechnologyBusiness FormationResearch and Development (R&D)Molecular BiologyStart-UpsMicrobiologyEntrepreneurshipFdaTeam ManagementRegulated Product DevelopmentRt-PcrProduct DevelopmentTechnology Transfer

ABOUT SUNDARESH BRAHMASANDRA

I’m passionate about translating breakthrough ideas into diagnostics that truly improve patient care. At DiaSorin, I lead Innovation, Assay R&D, Clinical Affairs, guiding talented teams that turn complex science into clinically impactful products.Previously, I co-led the conception, development, and growth of NeuMoDx, a fully automated molecular diagnostics platform company acquired by Qiagen, and co-founded HandyLab, developer of the BD MAX system acquired by BD. As a venture advisor and board member, I now help startups and investors advance transformative healthcare innovations. My mission is simple: empower teams to innovate with purpose — improving outcomes while reducing the cost and complexity of care.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Sundaresh Brahmasandra — Member, Investment Advisory Council at Clarevia Ventures in Ann Arbor, MI, US | Unifers